BAYER AG-REG (BAYN.DE) Fundamental Analysis & Valuation

FRA:BAYN • DE000BAY0017

40.015 EUR
+0.39 (+0.98%)
Last: Mar 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This BAYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

BAYN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. BAYN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

1

1. BAYN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BAYN was profitable.
  • In the past year BAYN had a positive cash flow from operations.
  • In multiple years BAYN reported negative net income over the last 5 years.
  • BAYN had a positive operating cash flow in 4 of the past 5 years.
BAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

  • With a Return On Assets value of -0.19%, BAYN is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
  • BAYN's Return On Equity of -0.67% is on the low side compared to the rest of the industry. BAYN is outperformed by 64.81% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.80%, BAYN is doing worse than 62.96% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BAYN is significantly below the industry average of 14.78%.
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROIC 1.8%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
BAYN.DE Yearly ROA, ROE, ROICBAYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • BAYN's Operating Margin of 4.20% is on the low side compared to the rest of the industry. BAYN is outperformed by 64.81% of its industry peers.
  • In the last couple of years the Operating Margin of BAYN has declined.
  • The Gross Margin of BAYN (56.35%) is worse than 70.37% of its industry peers.
  • In the last couple of years the Gross Margin of BAYN has declined.
Industry RankSector Rank
OM 4.2%
PM (TTM) N/A
GM 56.35%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
BAYN.DE Yearly Profit, Operating, Gross MarginsBAYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BAYN.DE Health Analysis

2.1 Basic Checks

  • BAYN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for BAYN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BAYN.DE Yearly Shares OutstandingBAYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
BAYN.DE Yearly Total Debt VS Total AssetsBAYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 0.98, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
  • BAYN has a worse Altman-Z score (0.98) than 72.22% of its industry peers.
  • BAYN has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as BAYN would need 10.07 years to pay back of all of its debts.
  • BAYN's Debt to FCF ratio of 10.07 is on the low side compared to the rest of the industry. BAYN is outperformed by 64.81% of its industry peers.
  • BAYN has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • BAYN's Debt to Equity ratio of 1.11 is on the low side compared to the rest of the industry. BAYN is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Altman-Z 0.98
ROIC/WACC0.26
WACC6.94%
BAYN.DE Yearly LT Debt VS Equity VS FCFBAYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that BAYN should not have too much problems paying its short term obligations.
  • BAYN has a Current ratio of 1.14. This is in the lower half of the industry: BAYN underperforms 64.81% of its industry peers.
  • A Quick Ratio of 0.71 indicates that BAYN may have some problems paying its short term obligations.
  • BAYN's Quick ratio of 0.71 is on the low side compared to the rest of the industry. BAYN is outperformed by 81.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.71
BAYN.DE Yearly Current Assets VS Current LiabilitesBAYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BAYN.DE Growth Analysis

3.1 Past

  • BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.99%.
  • Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.00% on average per year.
EPS 1Y (TTM)-11.99%
EPS 3Y-17.58%
EPS 5Y-7%
EPS Q2Q%-85.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.22% on average over the next years.
  • The Revenue is expected to grow by 2.62% on average over the next years.
EPS Next Y5.3%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
EPS Next 5Y6.22%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAYN.DE Yearly Revenue VS EstimatesBAYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
BAYN.DE Yearly EPS VS EstimatesBAYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. BAYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • BAYN is valuated reasonably with a Price/Earnings ratio of 9.01.
  • 94.44% of the companies in the same industry are more expensive than BAYN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.15. BAYN is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 8.55, the valuation of BAYN can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, BAYN is valued cheaply inside the industry as 98.15% of the companies are valued more expensively.
  • BAYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.01
Fwd PE 8.55
BAYN.DE Price Earnings VS Forward Price EarningsBAYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BAYN is valued a bit cheaper than 66.67% of the companies in the same industry.
  • 87.04% of the companies in the same industry are more expensive than BAYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.99
EV/EBITDA 11.39
BAYN.DE Per share dataBAYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • BAYN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.7
PEG (5Y)N/A
EPS Next 2Y6.88%
EPS Next 3Y9.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BAYN.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.29%, BAYN is not a good candidate for dividend investing.
  • BAYN's Dividend Yield is slightly below the industry average, which is at 1.91.
  • Compared to an average S&P500 Dividend Yield of 1.82, BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.29%

5.2 History

  • The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
BAYN.DE Yearly Dividends per shareBAYN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of BAYN are negative and hence is the payout ratio. BAYN will probably not be able to sustain this dividend level.
DP-65.15%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
BAYN.DE Yearly Income VS Free CF VS DividendBAYN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

Find the best dividend stocksShow peers with best dividend

BAYN.DE Fundamentals: All Metrics, Ratios and Statistics

BAYER AG-REG

FRA:BAYN (3/11/2026, 7:00:00 PM)

40.015

+0.39 (+0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04
Earnings (Next)05-12
Inst Owners51.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.31B
Revenue(TTM)N/A
Net Income(TTM)-198.00M
Analysts73.1
Price Target42.36 (5.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.29%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)0%
PT rev (3m)29.98%
EPS NQ rev (1m)6.05%
EPS NQ rev (3m)17.87%
EPS NY rev (1m)1.17%
EPS NY rev (3m)1.83%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 9.01
Fwd PE 8.55
P/S 0.86
P/FCF 9.99
P/OCF 5.85
P/B 1.33
P/tB N/A
EV/EBITDA 11.39
EPS(TTM)4.44
EY11.1%
EPS(NY)4.68
Fwd EY11.7%
FCF(TTM)4.01
FCFY10.01%
OCF(TTM)6.84
OCFY17.1%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)1.7
PEG (5Y)N/A
Graham Number54.84
Profitability
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROCE 2.56%
ROIC 1.8%
ROICexc 2%
ROICexgc 6.8%
OM 4.2%
PM (TTM) N/A
GM 56.35%
FCFM 8.58%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Debt/EBITDA 5.32
Cap/Depr 66.1%
Cap/Sales 6.08%
Interest Coverage 1.09
Cash Conversion 109.39%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.71
Altman-Z 0.98
F-Score5
WACC6.94%
ROIC/WACC0.26
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.99%
EPS 3Y-17.58%
EPS 5Y-7%
EPS Q2Q%-85.26%
EPS Next Y5.3%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
EPS Next 5Y6.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.41%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.63%
EBIT Next 3Y21.19%
EBIT Next 5Y13.99%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%

BAYER AG-REG / BAYN.DE FAQ

What is the fundamental rating for BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to BAYN.DE.


What is the valuation status of BAYER AG-REG (BAYN.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.


How profitable is BAYER AG-REG (BAYN.DE) stock?

BAYER AG-REG (BAYN.DE) has a profitability rating of 1 / 10.


How financially healthy is BAYER AG-REG?

The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.


How sustainable is the dividend of BAYER AG-REG (BAYN.DE) stock?

The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.